why choose us

First received: October 27, 2023

Clinical Trial: A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

Study Status: Completed

Recruit Status: RECRUITING

Condition: NonSegmental Vitiligo

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Brief Summary: This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Read more